Overall, the above data taken together support the notion that impaired sponge angiogenic capacity during the course of diabetes might stem, at least in part, from a combination of decreased VEGF and/or cFLIP expression and increased activity of TSP- or PEDF-NF-κB-FasL-dependent signaling. This evidence concerns the gene THBS1 and diabetes mellitus.